This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Mycobacterium tuberculosis 6 kDa Early Secretory Antigenic Target (esxA), C-His
Product Overview
BioVenic's Recombinant Mycobacterium tuberculosis 6 kDa Early Secretory Antigenic Target (esxA), C-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 10.7 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Mycobacterium tuberculosis 6 kDa early secretory antigenic Target , also known as esat6, is a key virulence factor in the pathogenesis of tuberculosis. In veterinary medicine, ESAT-6 plays a significant role in understanding and combating. Mycobacterium bovis, the causative agent of bovine tuberculosis, which is closely related to M. tuberculosis. This protein is crucial for the survival of the bacteria within macrophages and its spread to other cells. It is involved in the inhibition of autophagy, triggering of necrosis, and the stimulation of cytokine production, which creates a chronic proinflammatory environment at the site of infection. Additionally, ESAT-6 is a major target for diagnostic tests and vaccine development due to its immunodominant nature . Understanding the role of ESAT-6 in disease progression can guide therapeutic interventions and help in the development of more effective vaccines for animals, thereby controlling the spread of tuberculosis in veterinary populations.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.